A detailed history of Cnb Bank transactions in Abbott Laboratories stock. As of the latest transaction made, Cnb Bank holds 7,338 shares of ABT stock, worth $836,605. This represents 0.37% of its overall portfolio holdings.

Number of Shares
7,338
Previous 7,530 2.55%
Holding current value
$836,605
Previous $855,000 10.88%
% of portfolio
0.37%
Previous 0.42%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$100.73 - $112.44 $19,340 - $21,588
-192 Reduced 2.55%
7,338 $762,000
Q1 2024

May 02, 2024

SELL
$109.52 - $120.96 $11,280 - $12,458
-103 Reduced 1.35%
7,530 $855,000
Q4 2023

Jan 31, 2024

SELL
$90.19 - $110.4 $29,852 - $36,542
-331 Reduced 4.16%
7,633 $840,000
Q3 2023

Nov 02, 2023

BUY
$95.53 - $114.62 $40,313 - $48,369
422 Added 5.6%
7,964 $771,000
Q2 2023

Aug 08, 2023

SELL
$100.78 - $112.29 $11,892 - $13,250
-118 Reduced 1.54%
7,542 $822,000
Q1 2023

May 10, 2023

SELL
$96.86 - $114.01 $9,589 - $11,286
-99 Reduced 1.28%
7,660 $775,000
Q4 2022

Feb 13, 2023

SELL
$95.06 - $111.52 $9,696 - $11,375
-102 Reduced 1.3%
7,759 $852,000
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $10,450 - $12,099
-108 Reduced 1.36%
7,861 $761,000
Q2 2022

Aug 19, 2022

SELL
$102.07 - $123.37 $33,683 - $40,712
-330 Reduced 3.98%
7,969 $866,000
Q2 2022

Aug 10, 2022

BUY
$102.07 - $123.37 $20,209 - $24,427
198 Added 2.44%
8,299 $902,000
Q1 2022

Apr 13, 2022

SELL
$114.02 - $139.04 $35,688 - $43,519
-313 Reduced 3.72%
8,101 $959,000
Q4 2021

Jan 31, 2022

SELL
$115.53 - $141.46 $14,094 - $17,258
-122 Reduced 1.43%
8,414 $1.18 Million
Q3 2021

Nov 02, 2021

SELL
$116.66 - $129.06 $47,597 - $52,656
-408 Reduced 4.56%
8,536 $1.01 Million
Q2 2021

Jul 29, 2021

BUY
$105.79 - $124.53 $6,558 - $7,720
62 Added 0.7%
8,944 $1.04 Million
Q1 2021

May 03, 2021

BUY
$108.84 - $128.23 $28,189 - $33,211
259 Added 3.0%
8,882 $1.06 Million
Q4 2020

Jan 27, 2021

BUY
$105.0 - $114.42 $840 - $915
8 Added 0.09%
8,623 $944,000
Q3 2020

Oct 26, 2020

SELL
$91.64 - $111.29 $171,550 - $208,334
-1,872 Reduced 17.85%
8,615 $938,000
Q2 2020

Jul 14, 2020

SELL
$76.57 - $98.0 $50,383 - $64,484
-658 Reduced 5.9%
10,487 $959,000
Q1 2020

May 13, 2020

SELL
$62.82 - $91.86 $92,219 - $134,850
-1,468 Reduced 11.64%
11,145 $879,000
Q4 2019

Jan 27, 2020

SELL
$78.51 - $87.4 $21,040 - $23,423
-268 Reduced 2.08%
12,613 $1.1 Million
Q3 2019

Nov 04, 2019

SELL
$81.84 - $88.74 $241,755 - $262,137
-2,954 Reduced 18.65%
12,881 $1.08 Million
Q2 2019

Aug 14, 2019

SELL
$72.88 - $85.0 $92,193 - $107,525
-1,265 Reduced 7.4%
15,835 $1.33 Million
Q1 2019

Apr 29, 2019

BUY
$66.22 - $80.06 $208,460 - $252,028
3,148 Added 22.56%
17,100 $1.37 Million
Q4 2018

Feb 06, 2019

BUY
$65.56 - $74.27 $108,960 - $123,436
1,662 Added 13.52%
13,952 $1.01 Million
Q3 2018

Nov 13, 2018

BUY
$60.81 - $73.36 $3,770 - $4,548
62 Added 0.51%
12,290 $901,000
Q2 2018

Aug 14, 2018

BUY
$57.57 - $63.54 $38,514 - $42,508
669 Added 5.79%
12,228 $745,000
Q1 2018

May 11, 2018

BUY
$56.27 - $63.62 $149,396 - $168,911
2,655 Added 29.82%
11,559 $693,000
Q4 2017

Feb 20, 2018

BUY
$53.68 - $57.47 $477,966 - $511,712
8,904
8,904 $508,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Cnb Bank Portfolio

Follow Cnb Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cnb Bank, based on Form 13F filings with the SEC.

News

Stay updated on Cnb Bank with notifications on news.